{"id":53394,"date":"2025-11-03T12:26:18","date_gmt":"2025-11-03T06:56:18","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=53394"},"modified":"2025-11-03T12:26:44","modified_gmt":"2025-11-03T06:56:44","slug":"jubilant-pharmova-q2-results-2025","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/jubilant-pharmova-q2-results-2025\/","title":{"rendered":"Jubilant Pharmova Q2 Results 2025 Highlights: Net Profit Rises by 17.02% &#038; Revenue Up 12.2% YoY"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Q2 Results&nbsp;<\/em><\/strong><\/a><\/p><p><strong>Jubilant Pharmova <\/strong><strong><em>Q2 Results FY26<\/em><\/strong>: During Q2 FY26, Jubilant Pharmova&#8217;s profit increased 17.02% YoY, while revenue increased by 12.22% YoY. The company posted robust numbers, with Q2 PAT at \u20b9120.30 crores and revenue at \u20b91,966.40 crores. <a href=\"https:\/\/univest.in\/stocks\/jublpharm\/jubilant-pharmova-ltd-share-price-today\">Jubilant Pharmova<\/a> showed its Q2 results on 31st October 2025.&nbsp;&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-pharmova-q2-results-2025\/#Jubilant_Pharmova_Q2_Results_FY26_Extracts_of_FY25_FY26\" title=\"Jubilant Pharmova Q2 Results FY26: Extracts of FY25 &amp; FY26\">Jubilant Pharmova Q2 Results FY26: Extracts of FY25 &amp; FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-pharmova-q2-results-2025\/#Jubilant_Pharmova_Q2_Results_FY26_Highlights_Q2_FY26_vs_FY25\" title=\"Jubilant Pharmova Q2 Results FY26 Highlights (Q2 FY26 vs FY25)\">Jubilant Pharmova Q2 Results FY26 Highlights (Q2 FY26 vs FY25)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-pharmova-q2-results-2025\/#About_Jubilant_Pharmova_Limited\" title=\"About Jubilant Pharmova Limited\">About Jubilant Pharmova Limited<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-pharmova-q2-results-2025\/#Jubilant_Pharmova_Share_Price_Performance\" title=\"Jubilant Pharmova Share Price Performance\">Jubilant Pharmova Share Price Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-pharmova-q2-results-2025\/#What_Analysts_Expect_Post_Q2_Results\" title=\"What Analysts Expect Post Q2 Results?\">What Analysts Expect Post Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-pharmova-q2-results-2025\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Jubilant_Pharmova_Q2_Results_FY26_Extracts_of_FY25_FY26\"><\/span><strong>Jubilant Pharmova Q2 Results FY26: Extracts of FY25 &amp; FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Particulars<\/strong><\/td><td colspan=\"2\"><strong>Consolidated Figures<\/strong><\/td><td colspan=\"2\"><strong>Standalone Figures<\/strong><\/td><\/tr><tr><td><\/td><td><strong>30th Sep 2025<\/strong><\/td><td><strong>30 Sept 2024<\/strong><\/td><td><strong>30th Sept 2025<\/strong><\/td><td><strong>30th Sept 2024<\/strong><\/td><\/tr><tr><td><strong>Revenue from Operations<\/strong><\/td><td>\u20b91,966.40<\/td><td>\u20b91,752.30<\/td><td>\u20b966.40<\/td><td>\u20b961.40<\/td><\/tr><tr><td><strong>Profit Before Tax (PBT)<\/strong><\/td><td>\u20b9351.20<\/td><td>\u20b9311.10<\/td><td>\u20b912.60<\/td><td>\u20b929.50<\/td><\/tr><tr><td><strong>Profit After Tax (PAT)<\/strong><\/td><td>\u20b9120.30<\/td><td>\u20b9102.80<\/td><td>-\u20b948.00<\/td><td>\u20b914.30<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Jubilant_Pharmova_Q2_Results_FY26_Highlights_Q2_FY26_vs_FY25\"><\/span><strong>Jubilant Pharmova Q2 Results FY26 Highlights (Q2 FY26 vs FY25)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Jubilant Pharmova clocked Q2 FY26 consolidated revenue of \u20b91,966.40 crores vs \u20b91,752.30 crores.\u00a0<\/li>\n\n<li>On the profit front, Jubilant Pharmova earned a consolidated PAT of \u20b9120.30 crore in Q2 FY26. During FY25, the company\u2019s PAT stood at \u20b9102.80 crore.<\/li>\n\n<li>According to the consolidated figures, Jubilant Pharmova&#8217;s quarterly PAT increased by 17.02% YoY, while revenue increased by 12.22%.<\/li>\n\n<li>Jubilant Pharmova clocked Q2 FY26 standalone revenue of \u20b966.40 crores vs \u20b961.40 crores.\u00a0<\/li>\n\n<li>On the profit front, Jubilant Pharmova earned a standalone PAT of -\u20b948.00 crore in Q2 FY26. During FY25, the company\u2019s PAT stood at \u20b914.30 crore.<\/li>\n\n<li>According to the standalone figures, Jubilant Pharmova&#8217;s quarterly PAT decreased by 435.66% YoY, while revenue increased by 8.14%.<\/li><\/ul><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Jubilant_Pharmova_Limited\"><\/span><strong>About Jubilant Pharmova Limited<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Jubilant Pharmova is a global integrated pharmaceutical company with three primary business segments: contract Research and development services, Pharmaceuticals, and Proprietary Novel Drugs. The Pharmaceuticals segment includes radiopharmaceuticals, allergy immunotherapy, and contract manufacturing of sterile injectables and generic formulations. The company has a significant presence in the US, operating the second-largest radiopharmacy network with 46 locations, and manufacturing facilities in India, the US, and Canada, which are approved by the US FDA.&nbsp;&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Jubilant_Pharmova_Share_Price_Performance\"><\/span><strong>Jubilant Pharmova Share Price Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>On the opening bell on 3rd November 2025, Jubilant Pharmova shares opened at \u20b91,109.80 per share. However, the initial gains have since eroded, and Jubilant Pharmova shares are trading at \u20b91,141.60 per share, higher than the opening price.&nbsp;&nbsp;&nbsp;&nbsp;<\/p><p>Considering the long-term achievements, Jubilant Pharmova shares have yielded returns of approximately 25.73% over the past 6 months, and 1-year returns stand at -8.85%. Over the maximum timeframe, Jubilant Pharmova shares delivered a 27.71% return to investors.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Analysts_Expect_Post_Q2_Results\"><\/span><strong>What Analysts Expect Post Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Following Jubilant Pharmova&#8217;s robust Q2 results, analysts expect its share price to rise. According to analysts, Jubilant Pharmova&#8217;s share price could reach \u20b91,235.30 per share in the coming year and, in a downturn, could fall to \u20b9 1,120.60 per share. However, one must ignore stock market volatility and invest in Jubilant Pharmova&#8217;s shares after thorough research.&nbsp;<\/p><p><strong><em>Disclaimer:<\/em><\/strong><em> Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/nestle-q2-results-2025\">Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to \u20b9743.17 Crore; Revenue Up 10.57% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/inspira-enterprise-india-ipo-details\">Inspira Enterprise India IPO Details: Everything You Should Know about<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/swaraj-engines-q2-results-fy26\">Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to \u20b949 Crore; Revenue Up 8.62% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/hdb-financial-q2-results-2025\">HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to \u20b9581 Crore; Revenue Up 13.42% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bel-gears-q2-results-expectations\">BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/paytm-q2-results-expectations\">Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/blue-dart-q2-results-expectations\">Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click and Sign Up to Get Live Updates on Q2 Results&nbsp; Jubilant Pharmova Q2 Results FY26: During Q2 FY26, Jubilant Pharmova&#8217;s profit increased 17.02% YoY, while revenue increased by 12.22% YoY. The company posted robust numbers, with Q2 PAT at \u20b9120.30 crores and revenue at \u20b91,966.40 crores. Jubilant Pharmova showed its Q2 results on 31st<\/p>\n","protected":false},"author":23,"featured_media":53395,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3019],"class_list":["post-53394","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-jubilant-pharmova-q2-results-2025"],"metadata":{"_edit_lock":["1762153004:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Jubilant Pharmova Q2 Results 2025: Net Profit Rises 17.02% YoY"],"rank_math_description":["Discover the recent updates on the Jubilant Pharmova Q2 results for FY26. Q2 profit rose 17.02% YoY to \u20b9120.30 crore, and revenue increased by 12.22% YoY. Learn more about the company's financials.\r\n"],"rank_math_focus_keyword":["Jubilant Pharmova Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["53395"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["4305"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/jubilant-pharmova-q2-results-2025"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/03122145\/Jubilant-Pharmova-Q2-Results-2025-Net-Profit-Rises-17.02-YoY.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/53394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=53394"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/53394\/revisions"}],"predecessor-version":[{"id":53396,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/53394\/revisions\/53396"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/53395"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=53394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=53394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=53394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}